Related Experiment Video
Updated: Dec 15, 2025
06:59
Catheter-based Endovascular Angioplasty for Fibrosing Mediastinitis-associated Pulmonary Vein Stenosis
Published on: August 26, 2025
418
Second SVC stent treatment for tumour ingrowth
Yutaka Takahara1, Yoko Ishige1, Ikuyo Shionoya1
1Department of Respiratory Medicine Kanazawa Medical University Uchinada Japan.
Respirology Case Reports
|July 10, 2020
Summary
Recurrent superior vena cava (SVC) syndrome in lung cancer patients can be treated with additional stent placement. This approach offers a viable option for tumor ingrowth, even in patients with poor performance status.
Area of Science:
- Interventional Oncology
- Thoracic Oncology
- Vascular Interventions
Background:
- Superior vena cava (SVC) syndrome is a critical complication of lung cancer.
- Recurrent SVC syndrome poses treatment challenges, particularly in patients with poor performance status.
Purpose of the Study:
- To report a case of recurrent SVC syndrome secondary to lung cancer.
- To evaluate the efficacy of additional stent placement for managing tumor ingrowth causing SVC syndrome.
Main Methods:
- A case of lung cancer with recurrent SVC syndrome was treated.
- Additional stent placement was performed to address tumor ingrowth.
Main Results:
- Successful treatment of recurrent SVC syndrome was achieved with additional stent placement.
- The intervention was feasible even in a patient with poor performance status.
Conclusions:
- Additional SVC stent placement is a potential treatment option for recurrent SVC syndrome due to tumor ingrowth.
- This strategy may be beneficial for lung cancer patients with poor performance status.
